Detalles de la búsqueda
1.
HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives.
Diabetologia
; 67(2): 290-300, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914981
2.
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.
Diabetologia
; 65(1): 88-100, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34642772
3.
Index60 as an additional diagnostic criterion for type 1 diabetes.
Diabetologia
; 64(4): 836-844, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33496819
4.
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.
Diabetologia
; 63(3): 588-596, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31768570
5.
Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals.
Diabetes Obes Metab
; 22(6): 997-1000, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32003110
6.
Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes.
Pediatr Diabetes
; 20(4): 408-413, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30891858
7.
Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
Pediatr Diabetes
; 20(3): 263-270, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30628751
8.
The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
Diabetologia
; 61(1): 84-92, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28956083
9.
The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms.
Curr Diab Rep
; 18(11): 115, 2018 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30259209
10.
The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.
Pediatr Diabetes
; 19(3): 403-409, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29171129
11.
Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
Diabetologia
; 60(8): 1409-1422, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28500393
12.
Do-It-Yourself Diabetes Management: Perspectives of a Patient, a Physician, and an Ethicist.
Clin Diabetes
; 40(1): 70-74, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35221474
13.
The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.
Diabetologia
; 59(6): 1186-95, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26995649
14.
The development, validation, and utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS).
Curr Diab Rep
; 15(8): 49, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26077017
15.
Comparisons of Metabolic Measures to Predict T1D vs. Detect a Preventive Treatment Effect in High-Risk Individuals.
J Clin Endocrinol Metab
; 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267821
16.
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
Diabetes Care
; 47(6): 1048-1055, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621411
17.
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.
Diabetes Care
; 46(5): 1098-1105, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000695
18.
Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.
J Clin Endocrinol Metab
; 107(8): e3273-e3280, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524749
19.
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.
J Clin Endocrinol Metab
; 107(10): 2784-2792, 2022 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880956
20.
Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.
Diabetes Care
; 45(2): 311-318, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34853027